Akiko Saito-Moriya

14PUBLICATIONS
105CO-AUTHORS
Adolescent healthMedical infection agents (incl. prions)Infant and child healthRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 15, 2026
Prognosis and treatment-related toxicities in Down syndrome acute lymphoblastic leukemia in JCCG ALL-B12.

|Apr 29, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

|Feb 25, 2026
Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph+ Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13.

Atsushi Sato, Yuichi Kodama, Hirohide Kawasaki

|Jul 16, 2025
Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia.

Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh

|Nov 12, 2024
JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL.

Motohiro Kato, Yasuhiro Okamoto, Toshihiko Imamura

|Jun 26, 2024
Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma.

Satoshi Yamasaki, Hiroatsu Iida, Akio Saito

Pageof 3

Frequent Collaborators

5 joint publications

Katsuyoshi Koh

5 joint publications

Takao Deguchi

4 joint publications

Nobutaka Kiyokawa

4 joint publications

Daisuke Tomizawa